Jump Financial, LLC Roivant Sciences Ltd. Transaction History

Jump Financial, LLC

  • $4.8 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 21, 2024
BUY
$9.76 - $13.19 $4.07 Million - $5.5 Million
416,667 New
416,667 $4.87 Million
Q3 2023

Nov 07, 2023
BUY
$9.76 - $13.19 $4.07 Million - $5.5 Million
416,667 New
416,667 $4.87 Million
Q4 2022

Feb 13, 2023
BUY
$3.36 - $7.99 $558,445 - $1.33 Million
166,204 New
166,204 $1.33 Million
Q2 2022

Aug 09, 2022
SELL
$2.81 - $4.84 $115,892 - $199,616
-41,243 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$4.74 - $9.91 $195,491 - $408,718
41,243 New
41,243 $203,000

Others Institutions Holding ROIV

# of Institutions
314
Shares Held
496M
Call Options Held
991K
Put Options Held
1.15M
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.23B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email